News

Our bodies contain two types of fat: white fat and brown fat. While white fat stores calories, brown fat burns energy and could help us lose weight. Now, scientists have found a way of making the white fat ‘browner’ and increasing the efficiency of brown fat.

Imagine one drug that can target and kill malignant cells for some patients with many types of cancer. A new drug called Vitrakvi (larotrectinib), now approved by the FDA, shows promise of doing just that for both adults and children with a variety of sometimes rare cancers that share one specific genetic mutation.

Loss-of-function screening showed that hantaviruses gain entry to lung cells by “unlocking” a cell-surface receptor called protocadherin-1 (PCDH1).

The discovery of a new gene in zebrafish could lead to a better understanding of how exposure to chemicals leads to disease in humans, according to a new Oregon State University study.

Researchers have found that a protein in the cell membranes of sperm plays a key role in how they find their way to eggs.

A DNA vaccine tested in mice reduces accumulation of both types of toxic proteins associated with Alzheimer’s disease, according to research that scientists say may pave the way to a clinical trial.

Cancer treatments are suspected to accelerate certain aging processes in the body. A new study has found that indicators of such biological aging correlate with declines in cognitive function in women who had undergone breast cancer treatment several years earlier.

The internet of things and the cloud are entering the world of chemical research and production. Researchers have used remote servers in Japan to autonomously optimize conditions to synthesize drugs in a British laboratory.

Organogenesis is a self-organizing process of multiple cells in 3D space. Understanding this organization is becoming increasingly important, particularly with the increasing popularity of organ-on-a-chip models.

While probiotics are often used to treat acute gastroenteritis (also known as infectious diarrhea) in children, the latest evidence shows no significant differences in outcomes, compared to a placebo.